about
Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyondThe gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cellsYoung patients with non-germinal center B-cell-like diffuse large B-cell lymphoma benefit from intensified chemotherapy with ACVBP plus rituximab compared with CHOP plus rituximab: analysis of data from the Groupe d'Etudes des Lymphomes de l'Adulte/Pathologic and clinical features of 77 Hodgkin's lymphoma patients treated in a lymphoma protocol (LNH87): a GELA study.Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter studyGene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphomaGene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal typeGammadelta T-cell lymphomas.CD10 delineates a subset of human IL-4 producing follicular helper T cells involved in the survival of follicular lymphoma B cellsTargeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELABreast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.Idh1 mutations contribute to the development of T-cell malignancies in genetically engineered miceClinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium.CD1d-restricted peripheral T cell lymphoma in mice and humans.DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in miceDiagnostic and Biological Significance of KIR Expression Profile Determined by RNA-Seq in Natural Killer/T-Cell Lymphoma.CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features.Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets.Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations.Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trialIndolent T-cell lymphoproliferative disease of the gastrointestinal tract.Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden.Primary breast non-Hodgkin's lymphoma: a large single center study of initial characteristics, natural history, and prognostic factors.The mutator pathway is a feature of immunodeficiency-related lymphomas.The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid developmentNew biomarkers in T-cell lymphomas.Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials.Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics.Molecular underpinning of extranodal NK/T-cell lymphoma.VIII. New markers in peripheral T-cell lymphomas: more entities or more confusion?The microenvironment in T-cell lymphomas: emerging themes.Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas.Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma.Immunomodulatory antibodies for the treatment of lymphoma: Report on the CALYM WorkshopPrognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium.Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network.Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3(-/dim)CD4(+) population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic.Adult T cell leukemia aggressivenness correlates with loss of both 5-hydroxymethylcytosine and TET2 expression.MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study.
P50
Q27027493-26CA2829-6A66-43EB-A9C7-954B57762247Q28287097-4C25C393-2012-4F39-9563-43660CF0FA9EQ30868666-5B30C3FB-B6B1-479F-A157-4B71CF071340Q32063856-E8D59736-7D58-4E0E-9335-D73E44B9DEC2Q33434137-2799892C-2F24-47C3-8F74-33E7342AB267Q33585243-FD545419-FCEA-4409-90F2-6EE40F46A79CQ33677463-1B5A9895-4CF3-4E2E-A8F9-6AD1AC4B739FQ35183217-34DAE364-95E9-47D4-9618-A7D0B01A5318Q35460668-1AB1D239-D367-432F-9B04-37DF00FBEC8EQ36366982-613C2098-A5EF-4611-9A87-DCD7D9B33E27Q36490331-6F24CF03-3E0E-4AE5-ADC0-D7BF14AAA924Q36563148-5CED3940-99F0-4FD5-91FA-3317F129ACE6Q36591293-D53BAFA6-F3B2-4D9C-B382-88F570051EA1Q36747057-A05AF210-435C-4232-B3E1-9067A099058BQ36863110-E00599A6-E0B6-4A4C-89B2-36F8401366D5Q36908743-2F83BE8A-59C0-45A5-90A2-4F1634BAF044Q36990211-465E619D-CD25-4A16-A627-C98C98B782C3Q37060660-955696F6-17C9-42CC-BB59-86D51FCC2F75Q37187642-FBD98272-FAE5-4D9C-B1BB-6BC5CF3080D1Q37257158-A75A980A-3FBF-408D-8A24-803BB77D8DFCQ37273186-22AEDFA4-386B-406D-9BDC-03ACBAAC0D97Q37334706-EEAF83B3-AD62-4A65-BF3F-F6ED5B9B5201Q37352773-DA978F69-06B1-49B7-96C2-FDF867E8610AQ37387184-594683EE-445A-4EF3-942A-C513CD57F489Q37415820-2A1316A8-6EA3-46D8-A570-E4B85C289339Q37549960-B87D57C7-F8D6-4664-BC7E-7EF4F0ED1AC1Q37992723-04AE8738-5904-4774-B51B-1A5EC569B30EQ38050433-6C306A75-66E8-4898-8289-753960E937F7Q38052774-67D160B5-0840-4972-B26D-F076E6E1D8B7Q38114561-71DDEED1-FEFB-4537-B0FC-237498DBE7C7Q38115228-5441C234-7A33-4567-9DA4-08CCC97BCFCCQ38169484-FE120D7B-5703-43BF-9283-981D87A3F4F9Q38519535-D909C2F9-CA5B-41C3-A284-BFC2C72C7D64Q38764010-D6BF732C-DF46-455D-93F8-5F6E7B80B5BEQ38821875-FD71B827-5651-498C-A4B0-3C19002B852FQ38836134-B6E413DB-11C1-40A2-BC0F-A90F250A1472Q39275138-80066081-6CEA-45C2-AE64-B9230384D956Q39677321-D1B41262-3579-415F-8B91-74C2CCB28202Q40053212-5463CEED-1CD2-46D6-8AE2-8EB7D248D7FCQ41355740-EE435C38-CE8A-441D-A29F-0C5CCCB25DC3
P50
description
researcher ORCID ID = 0000-0002-4243-905X
@en
wetenschapper
@nl
name
Philippe Gaulard
@ast
Philippe Gaulard
@en
Philippe Gaulard
@es
Philippe Gaulard
@nl
type
label
Philippe Gaulard
@ast
Philippe Gaulard
@en
Philippe Gaulard
@es
Philippe Gaulard
@nl
prefLabel
Philippe Gaulard
@ast
Philippe Gaulard
@en
Philippe Gaulard
@es
Philippe Gaulard
@nl
P214
P106
P21
P214
P31
P496
0000-0002-4243-905X
P735
P7859
viaf-203135587